Target intelligence / Profile preview

BCL10 antisense RNA 1 (BCL10-AS1)

Target: BCL10-AS1
Molecular classification: long non-coding RNA

Overview

BCL10 antisense RNA 1 (BCL10-AS1) is a long non-coding RNA transcribed from the antisense strand of the BCL10 gene locus. Unlike the protein-coding gene BCL10, which plays a central role in immune signaling and lymphoid malignancy, BCL10-AS1 has not been consistently characterized, is not recognized as a therapeutic target, and its biological functions and disease relevance remain largely unknown based on current literature and genetic knowledge.

Beyond the preview

Go deeper on BCL10 antisense RNA 1 (BCL10-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCL10 antisense RNA 1 (BCL10-AS1).

Explore the full profile